אפורציו iu 3000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 3000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 4000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 4000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 5000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 5000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 10,000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 10000 iu / 1 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 20,000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 20000 iu / 1 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
אפורציו iu 30,000
salomon,levin & elstein ltd - epoetin theta (r-huepo) 30000 iu / 1 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
סיזוניק
salomon,levin & elstein ltd - ethinylestradiol 0.01 mg; ethinylestradiol 0.03 mg - tablets - ethinylestradiol - seasonique is indicated for use by women to prevent pregnancy.
סיזוניק l
salomon,levin & elstein ltd - ethinylestradiol 0.01 mg; ethinylestradiol 0.02 mg - tablets - ethinylestradiol - seasonique l is indicated for use by women to prevent pregnancy.
אסטרוגנוס ® 0.3 מ"ג
salomon,levin & elstein ltd - estrogens conjugated 0.3 mg - tablets - conjugated estrogens - estrogenus tablets are indicated in the:1. treatment of moderate to severe vasomotor symptoms associated with menopause. 2. treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause. when prescribing solely for the treatment of moderate to severe vaginal dryness and pain with intercourse, topical vaginal products should be considered.
אסטרוגנוס ® 0.45 מ"ג
salomon,levin & elstein ltd - estrogens conjugated 0.45 mg - tablets - conjugated estrogens - estrogenus tablets are indicated in the:treatment of moderate to severe vasomotor symptoms associated with menopause.